NCT03481647 Evaluation of an Oral Care Programme for Head and Neck Cancer Patients
| NCT ID | NCT03481647 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Head and Neck Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2018-01-08 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2018-01-08 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the effect of an intensified oral care programme on prevalence, severity and duration of mucositis in patients undergoing treatment for cancer in the head and neck region. Patients in the control group get professional oral care once a week.
Eligibility Criteria
Inclusion Criteria: * Patients scheduled to receive full dose of curative RT including major salivary glands in the radiation field Exclusion Criteria: * Patients with recurrent cancer * Patients with severe cognitive impairment.
Contact & Investigator
Annica Almståhl, Assoc.prof
PRINCIPAL INVESTIGATOR
Göteborg University
Frequently Asked Questions
Who can join the NCT03481647 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03481647 currently recruiting?
Yes, NCT03481647 is actively recruiting participants. Contact the research team at annica.almstahl@odontologi.gu.se for enrollment information.
Where is the NCT03481647 trial being conducted?
This trial is being conducted at Gothenburg, Sweden, Jönköping, Sweden.
Who is sponsoring the NCT03481647 clinical trial?
NCT03481647 is sponsored by Göteborg University. The principal investigator is Annica Almståhl, Assoc.prof at Göteborg University. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.